Pfizer (PFE) reachead $26.91 at the closing of the latest trading day, reflecting a -0.83% change compared to its last close.

Roche's strategic acquisition of Poseida Pharmaceuticals positions them as a leader in the allogeneic cell therapy market.

Lithium Americas has unveiled a massive 85 year mine life for the Thacker Pass project, with a host of ASX juniors in the ...

Lundbeck’s drug portfolio faces patent expirations but shows growth potential. Find out why HLBBF stock could see upside with ...

The IoT MVNO market is experiencing significant growth, driven by increasing adoption of IoT devices, the deployment of 5G networks, and rising demand for cost-effective, reliable connectivity ...

Texas Attorney General Ken Paxton filed a notice of appeal on Wednesday to continue his lawsuit against Pfizer Inc., for its ...

MD Revolution has launched RevConnect Workflow, an embedded low-code/no-code integration platform that enables healthcare ...